Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guideline [PDF]
Andrea Giustina +8 more
openalex +1 more source
Acrostudy: un’esperienza più che decennale dell’uso di pegvisomant nella normale pratica clinica
S. Grottoli
semanticscholar +1 more source
Clinical Pharmacodynamic Effects of the Growth Hormone Receptor Antagonist Pegvisomant: Implications for Cancer Therapy [PDF]
Donghua Yin +5 more
openalex +1 more source
MON-311 Glucose Metabolism in Acromegaly Patients Resistant to First Generation Somatostatin Receptor Ligands Treated with Pegvisomant And/Or Pasireotide Lar [PDF]
Sabrina Chiloiro +9 more
openalex +1 more source
Predictors of Quality of Life in Acromegaly: No Consensus on Biochemical Parameters [PDF]
Alberto M. Pereira +6 more
core +1 more source
Acromegaly treatment and bone: a bidirectional relationship. [PDF]
Chiloiro S +6 more
europepmc +1 more source
Quality of Life in Acromegalic Patients during Long-Term Somatostatin Analog Treatment with and without Pegvisomant [PDF]
Sebastian Neggers +7 more
openalex +1 more source
Plasma Agouti-Related Protein Levels in Acromegaly and Effects of Surgical or Pegvisomant Therapy [PDF]
Pamela U. Freda +6 more
openalex +1 more source

